• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma.

作者信息

Dalvin Lauren A

机构信息

Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

J Ophthalmic Vis Res. 2022 Jan 21;17(1):1-3. doi: 10.18502/jovr.v17i1.10163. eCollection 2022 Jan-Mar.

DOI:10.18502/jovr.v17i1.10163
PMID:35194489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8850858/
Abstract
摘要

相似文献

1
Thiolated Chitosan-carboxymethyl Dextran Nanoparticles: Improving Intravitreal Drug Bioavailability for Retinoblastoma.硫醇化壳聚糖-羧甲基葡聚糖纳米颗粒：提高视网膜母细胞瘤玻璃体腔内药物的生物利用度
J Ophthalmic Vis Res. 2022 Jan 21;17(1):1-3. doi: 10.18502/jovr.v17i1.10163. eCollection 2022 Jan-Mar.
2
Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma.Cy5标记的巯基化和甲基化壳聚糖-羧甲基葡聚糖纳米颗粒在视网膜母细胞瘤动物模型中的生物分布
J Ophthalmic Vis Res. 2022 Jan 21;17(1):58-68. doi: 10.18502/jovr.v17i1.10171. eCollection 2022 Jan-Mar.
3
Erratum: Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma.勘误：Cy5标记的巯基化和甲基化壳聚糖-羧甲基葡聚糖纳米颗粒在视网膜母细胞瘤动物模型中的生物分布。
J Ophthalmic Vis Res. 2022 Apr 29;17(2):158-159. doi: 10.18502/jovr.v17i2.10826. eCollection 2022 Apr-Jun.
4
Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.拓扑替康纳米粒用于视网膜母细胞瘤眼内化疗的疗效。
Exp Eye Res. 2021 Mar;204:108423. doi: 10.1016/j.exer.2020.108423. Epub 2021 Jan 13.
5
Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.巯基化壳聚糖纳米粒经鼻腔给药给予亮丙瑞林：生物利用度和药代动力学特征。
Int J Pharm. 2012 May 30;428(1-2):164-70. doi: 10.1016/j.ijpharm.2012.02.044. Epub 2012 Mar 5.
6
Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole.巯基化羧甲基壳聚糖-接枝-环糊精纳米粒的合成与表征及其作为阿苯达唑药物载体的研究。
J Mater Sci Mater Med. 2013 Aug;24(8):1939-49. doi: 10.1007/s10856-013-4947-9. Epub 2013 May 12.
7
Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study.巯基化羧甲基葡聚糖作为hSET1反义寡核苷酸结肠递送的纳米载体：体外稳定性和效率研究
Mater Sci Eng C Mater Biol Appl. 2016 May;62:771-8. doi: 10.1016/j.msec.2016.02.009. Epub 2016 Feb 5.
8
Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer.巯基化壳聚糖修饰的 PLA-PCL-TPGS 纳米粒用于肺癌的口服化疗。
Nanoscale Res Lett. 2013 Feb 9;8(1):66. doi: 10.1186/1556-276X-8-66.
9
Thiolated Chitosan Microneedle Patch of Levosulpiride from Fabrication, Characterization to Bioavailability Enhancement Approach.左旋硫必利的硫醇化壳聚糖微针贴剂：从制备、表征到生物利用度提高方法
Polymers (Basel). 2022 Jan 20;14(3):415. doi: 10.3390/polym14030415.
10
Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery.甘露糖锚定季铵化壳聚糖/巯基化羧甲基壳聚糖复合纳米粒作为用于药物递送的黏附载体。
Carbohydr Polym. 2022 May 1;283:119174. doi: 10.1016/j.carbpol.2022.119174. Epub 2022 Jan 23.

本文引用的文献

1
Biodistribution of Cy5-labeled Thiolated and Methylated Chitosan-Carboxymethyl Dextran Nanoparticles in an Animal Model of Retinoblastoma.Cy5标记的巯基化和甲基化壳聚糖-羧甲基葡聚糖纳米颗粒在视网膜母细胞瘤动物模型中的生物分布
J Ophthalmic Vis Res. 2022 Jan 21;17(1):58-68. doi: 10.18502/jovr.v17i1.10171. eCollection 2022 Jan-Mar.
2
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries.视网膜母细胞瘤发病率上升：来自40个欧洲国家的结果
Ophthalmology. 2021 Sep;128(9):1369-1371. doi: 10.1016/j.ophtha.2021.01.024. Epub 2021 Jan 26.
3
Efficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma.拓扑替康纳米粒用于视网膜母细胞瘤眼内化疗的疗效。
Exp Eye Res. 2021 Mar;204:108423. doi: 10.1016/j.exer.2020.108423. Epub 2021 Jan 13.
4
Intravitreal hydrogels for sustained release of therapeutic proteins.眼内水凝胶用于治疗性蛋白的持续释放。
J Control Release. 2020 Oct 10;326:419-441. doi: 10.1016/j.jconrel.2020.07.031. Epub 2020 Jul 25.
5
Chitosan and its Derivatives for Ocular Delivery Formulations: Recent Advances and Developments.用于眼部给药制剂的壳聚糖及其衍生物：最新进展与发展
Polymers (Basel). 2020 Jul 8;12(7):1519. doi: 10.3390/polym12071519.
6
Global Retinoblastoma Presentation and Analysis by National Income Level.按国民收入水平对全球视网膜母细胞瘤的呈现与分析
JAMA Oncol. 2020 May 1;6(5):685-695. doi: 10.1001/jamaoncol.2019.6716.
7
Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience.玻璃体内化疗时代视网膜母细胞瘤的原发性动脉内化疗：五年经验
Ocul Oncol Pathol. 2019 Feb;5(2):139-146. doi: 10.1159/000491580. Epub 2018 Aug 21.
8
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery.壳聚糖纳米颗粒概述及其在非肠道给药中的应用
Pharmaceutics. 2017 Nov 20;9(4):53. doi: 10.3390/pharmaceutics9040053.
9
Intravitreally Injected Fluid Dispersion: Importance of Injection Technique.玻璃体内注射液体的分散：注射技术的重要性。
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1434-1441. doi: 10.1167/iovs.16-20543.
10
A comprehensive insight on ocular pharmacokinetics.关于眼部药代动力学的全面见解。
Drug Deliv Transl Res. 2016 Dec;6(6):735-754. doi: 10.1007/s13346-016-0339-2.